We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
News From the Centers for Disease Control and Prevention |

Q Fever Linked With Xenotourism

JAMA. 2015;314(18):1907. doi:10.1001/jama.2015.14803.
Text Size: A A A
Published online


Five people from New York State and a Canadian woman were diagnosed as having the zoonotic disease Q fever after traveling to Germany in May 2014 for treatment known as live cell therapy, according to a recent report. All 6 saw the same physician and subsequently tested positive for Coxiella burnetii, the agent that causes Q fever (Robyn MP et al. MMWR Morb Mortal Wkly Rep. 2015;64[38]:1071-1073).

Eye of Science/sciencesource.com

Live cell therapy, which isn’t available in the United States, involves injections of processed cells from organs or fetuses of nonhuman animals—in this case, fetal sheep cells. Practitioners claim the xenotransplantation treatment has anti-aging effects and can treat erectile dysfunction, depression, and joint, neurologic, heart, kidney, lung, endocrine, and liver diseases. No published data support these therapeutic claims, but serious adverse events have been reported, including anaphylaxis, vasculitis, encephalitis, polyradiculitis, clostridial infections, and death. The 5 US residents had traveled to Germany for the injections twice a year for the last 5 years along with a group of up to 10 other people, according to the report.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Graphic Jump LocationImage not available.

Eye of Science/sciencesource.com



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles